SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL)
IMCL 0.1590.0%Oct 5 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: 613 who wrote (2328)9/5/2002 3:14:10 PM
From: Cacaito  Read Replies (1) of 2515
 
..."any clue about the results so its continuation is meaningless."...

The expected for the end of the year Colon Cancer trial is not blinded, neither has concurrent controls, which is a high risk situation, cause the simmilar botched trial in the US showed the decrease efficacy from 22.5% (imcl) to 12.5% (bmy) to 10.5% (Fda) for the same data.

The Fda was asking for a mere 15% response of 50% tumor shrinkage. Nothing about survival which so far in ALL imcl data has NOT shown any increase in survival.

Iressa showed tumor shrinkage in about 20% of subjects, but the debacle came when they showed ZERO survival increase in large phase III. It seems that they are going to use Iressa in earlier stages (very long and expensive trial) of disease.

Erbitux control and blind trials are expected for end of 2004 maybe a little earlier. Their head and neck data recently presented was a dissapointment.

The german trial will showed reality: erbitux hardly works if at all, the Fda will demand (like it did for Iressa, and Tarceva, and Avastin) large phase III double blind and control subjects to showed increase SURVIVAL.

The yahonians imclowns hyper morons "sink" that the misinformation attack the Fda campaign works only one way, if the Fda officials feel threatened they could just nicely ask for SURVIVAL data and let Bmy/imclowns/merckKgaA to mess up among themselves.

The day I see an imcl insider buying $1M in shares in one chunk I will believe that they "sink" the drug is worth something. They will never risk that money in their garbage.

The continuation of trials it just seems a phantom screen to show the public that they are "working hard", the only thing the imclowns care now seems to be how to get all the cash into their pockets with "excersise options" reprice options" "commissions" "services" "consultancies" and maybe "share buyback showing confidence" and how they will share with the class action lawyers.

Ask the cocaine mula if he is investing back in imcl the $100M he made selling shares, of criminal sam if he will put the $150M in imcl, they talk a lot of confidence but the only thing they do is put their money far from imcl.

Look how easy sammy pledge $10 millions for his bail, if imcl will go so high He should stay in jail and put the $10M in imcl, but his temporary freedom is worth more than the garbage shares of imcl.

This one is soon heading for $1.

There is ZERO pipedream, forget about a pipeline !!!

The seeming base price of the stock is plain speculation on short term events driven by manipulators of leaks.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext